Gobbi M, Taddei C, Mennini T
Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy.
Life Sci. 1988;42(5):575-83. doi: 10.1016/0024-3205(88)90099-9.
In the present paper we confirm and extend previous studies showing heterogeneous 3H-imipramine (3H-IMI) binding sites. Inhibition curves of various drugs (serotonin, imipramine, desmethyl-imipramine, d-fenfluramine, d-norfenfluramine and indalpine, a potent serotonin uptake inhibitor) obtained using 2 nM 3H-IMI and in presence of 120 mM NaCl, confirmed the presence of at least three 3H-IMI binding sites: two of these (high and low affinities) were serotonin-insensitive while the third one was selectively inhibited by serotonin and indalpine with nanomolar affinities. Moreover, this last component was found to be selectively modulated by chronic imipramine treatment thus suggesting a closer relation to serotonin uptake mechanism. These data indicate that the use of a more selective inhibitors of the serotonin-sensitive component (like indalpine or serotonin itself) to define non specific 3H-IMI, may be of help in understanding its relation with serotonin uptake system.
在本论文中,我们证实并拓展了先前的研究,这些研究显示了3H-丙咪嗪(3H-IMI)结合位点具有异质性。使用2 nM 3H-IMI并在120 mM NaCl存在的情况下获得的各种药物(血清素、丙咪嗪、去甲丙咪嗪、右旋芬氟拉明、去甲右旋芬氟拉明和强效血清素摄取抑制剂茚达品)的抑制曲线,证实了至少存在三个3H-IMI结合位点:其中两个(高亲和力和低亲和力)对血清素不敏感,而第三个则被血清素和茚达品以纳摩尔亲和力选择性抑制。此外,发现最后这个组分可被慢性丙咪嗪治疗选择性调节,因此表明它与血清素摄取机制有更密切的关系。这些数据表明,使用对血清素敏感组分更具选择性的抑制剂(如茚达品或血清素本身)来定义非特异性3H-IMI,可能有助于理解其与血清素摄取系统的关系。